GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OTCPK:MBGPF) » Definitions » Cyclically Adjusted Book per Share

MBGPF (Moberg Pharma AB) Cyclically Adjusted Book per Share : $13.15 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Moberg Pharma AB Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Moberg Pharma AB's adjusted book value per share for the three months ended in Dec. 2024 was $1.339. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $13.15 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Moberg Pharma AB's average Cyclically Adjusted Book Growth Rate was -6.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Moberg Pharma AB was 0.20% per year. The lowest was 0.20% per year. And the median was 0.20% per year.

As of today (2025-05-05), Moberg Pharma AB's current stock price is $0.81995. Moberg Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $13.15. Moberg Pharma AB's Cyclically Adjusted PB Ratio of today is 0.06.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Moberg Pharma AB was 3.20. The lowest was 0.03. And the median was 0.10.


Moberg Pharma AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Moberg Pharma AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Cyclically Adjusted Book per Share Chart

Moberg Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 13.15

Moberg Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 8.47 15.70 16.09 13.15

Competitive Comparison of Moberg Pharma AB's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Cyclically Adjusted PB Ratio falls into.


;
;

Moberg Pharma AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Moberg Pharma AB's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.339/132.9872*132.9872
=1.339

Current CPI (Dec. 2024) = 132.9872.

Moberg Pharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201412 16.232 100.225 21.538
201503 15.969 99.950 21.247
201506 16.326 99.995 21.713
201509 16.776 100.228 22.259
201512 16.629 100.276 22.054
201603 16.447 100.751 21.709
201606 18.260 101.019 24.038
201609 18.560 101.138 24.405
201612 19.941 102.022 25.994
201703 20.342 102.022 26.516
201706 20.154 102.752 26.084
201709 21.972 103.279 28.292
201712 21.482 103.793 27.524
201803 22.129 103.962 28.307
201806 21.212 104.875 26.898
201809 21.174 105.679 26.646
201812 21.151 105.912 26.558
201903 38.620 105.886 48.505
201906 37.305 106.742 46.478
201909 38.329 107.214 47.543
202003 10.302 106.563 12.857
202006 0.000 107.498 0.000
202009 11.070 107.635 13.677
202012 0.000 108.296 0.000
202103 7.614 108.360 9.344
202106 7.677 108.928 9.373
202109 7.400 110.338 8.919
202112 6.978 112.486 8.250
202203 6.515 114.825 7.545
202206 3.652 118.384 4.103
202209 3.334 122.296 3.625
202212 3.488 126.365 3.671
202303 3.426 127.042 3.586
202306 3.312 129.407 3.404
202309 1.990 130.224 2.032
202312 2.129 131.912 2.146
202403 2.078 132.205 2.090
202406 1.933 132.716 1.937
202409 1.944 132.304 1.954
202412 1.339 132.987 1.339

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Moberg Pharma AB  (OTCPK:MBGPF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Moberg Pharma AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.81995/13.15
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Moberg Pharma AB was 3.20. The lowest was 0.03. And the median was 0.10.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Moberg Pharma AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Moberg Pharma AB Business Description

Industry
Traded in Other Exchanges
Address
Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.